TM
Treace Medical Concepts, Inc.
TMCI · NASDAQ
$4.50 -1.10% (-$0.05)
1M -2.17%
Market Cap $294.5M
P/E Ratio -
Div. Yield -
ROE 74.06%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
70 /100
Cheap P/B 4.35x
P/S 1.43x
EV/FFO N/A
Growth
87 /100
Growing Book val. growth 13.00%
Rev. growth 14.46%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 26.17%
Gross margin 79.45%
FCF margin 12.20%
Quality
14 /100
Poor ROA 32.87%
ROIC 37.54%
Asset turnover 1.13x
Debt
45 /100
Moderate Int. coverage -9.23x
Debt/Equity 1.07x
Current ratio 2.90x
Stability
62 /100
Moderate EPS volatility 4.06%
Beta 1.41x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TMCI
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
John T. Treace
Employees
450
Headquarters
Ponte Vedra
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report